Tranche

Wolf Acquisition Corp. Announces Shareholder Approval of Matters Relating to Business Combination with Frontera Gold Inc. and CX One Inc. and Completion of Additional Tranches of Non-Brokered Subscription Receipt Offering

Retrieved on: 
Wednesday, February 17, 2021

CX One is pleased to announce that, in connection with the Proposed Transaction, it has completed two additional tranches of a non-brokered private placement (the "Additional Tranches") of 2,916,708 subscription receipts ("Subscription Receipts") for additional proceeds of $350,004.96 (the "Proceeds").

Key Points: 
  • CX One is pleased to announce that, in connection with the Proposed Transaction, it has completed two additional tranches of a non-brokered private placement (the "Additional Tranches") of 2,916,708 subscription receipts ("Subscription Receipts") for additional proceeds of $350,004.96 (the "Proceeds").
  • Together with the initial offering completed on December 2, 2020 (the "Initial Offering"), CX One issued an aggregate of 20,991,058 Subscription Receipts for aggregate gross proceeds of $2,518,926.96.
  • The Subscription Receipts in the Additional Tranches were issued on identical terms to the Initial Offering.
  • No finder's fee or warrants were issued to any registered deals or other permitted individuals pursuant to the Additional Tranches.

MedMen Announces Equity Private Placement

Retrieved on: 
Wednesday, February 17, 2021

The Private Placement will be completed in tranches, with the initial tranche consisting of 7,800,000 Units for aggregate gross proceeds of US$2.9 million.

Key Points: 
  • The Private Placement will be completed in tranches, with the initial tranche consisting of 7,800,000 Units for aggregate gross proceeds of US$2.9 million.
  • MedMen is a U.S. cannabis retailer with flagship locations in Los Angeles, Las Vegas, Chicago, and New York.
  • MedMen offers a robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLyte, and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up.
  • Learn more about MedMen and The MedMen Foundation at www.medmen.com .

iSIGN Media Announces Closure of the Final Tranche of its Previously Announced Private Placement of up to $236,700

Retrieved on: 
Tuesday, February 16, 2021

TORONTO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- iSIGN Media Solutions Inc. (iSIGN or Company) (TSX-V: ISD) (OTC: ISDSF), a leading provider of interactive mobile proximity marketing and public security alert solutions announced that it has closed the third and final tranche (the Final Tranche) of its previously announced non-brokered private placement (Placement) of up to $236,700.

Key Points: 
  • TORONTO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- iSIGN Media Solutions Inc. (iSIGN or Company) (TSX-V: ISD) (OTC: ISDSF), a leading provider of interactive mobile proximity marketing and public security alert solutions announced that it has closed the third and final tranche (the Final Tranche) of its previously announced non-brokered private placement (Placement) of up to $236,700.
  • With this Final Tranche, the Company has received funds totaling $236,710 and has issued a total of 4,734,200 Units (Units) at a price of $0.05 per Unit.
  • The forward-looking statements are not historical facts but reflect iSIGN Medias current expectations regarding future results or events.
  • iSIGN Media assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

OSE Immunotherapeutics Enters a Loan Agreement of up to €25 Million with the European Investment Bank

Retrieved on: 
Monday, February 15, 2021

NANTES, France, Feb. 15, 2021 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today announced that the Company has signed a loan agreement of up to 25 million with the European Investment Bank (EIB).

Key Points: 
  • NANTES, France, Feb. 15, 2021 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) today announced that the Company has signed a loan agreement of up to 25 million with the European Investment Bank (EIB).
  • The loan facility of up to 25 million is divided into three tranches including two tranches of 10 million each and a third tranche of 5 million.
  • This development of OSE-279 will allow OSE Immunotherapeutics to have its own proprietary anti-PD-1 antibody and leverage it across OSEs product portfolio in combination with other drug candidates.
  • 550,000 additional warrants could be issued if the second tranche of 10 million is drawn by OSE Immunotherapeutics.

Babcock & Wilcox Enterprises Announces Proposed Public Offering of $110 Million of Senior Notes Due 2026

Retrieved on: 
Tuesday, February 9, 2021

Babcock & Wilcox Enterprises, Inc. ("B&W" or the "Company") (NYSE: BW) announced the commencement of an underwritten public offering of $110 million aggregate principal amount of senior notes due 2026.

Key Points: 
  • Babcock & Wilcox Enterprises, Inc. ("B&W" or the "Company") (NYSE: BW) announced the commencement of an underwritten public offering of $110 million aggregate principal amount of senior notes due 2026.
  • B&W expects to grant the underwriters a 30-day option to purchase additional senior notes in connection with the offering.
  • B&W and the senior notes both received a rating of BB+ from Egan-Jones Ratings Company, an independent, unaffiliated rating agency.
  • As part of the offering, B. Riley Financial, Inc. intends to exchange $35 million of its existing Tranche A term loan for $35 million principal amount of senior notes in the offering.

K9 Gold Announces Closing of Non Flow Through Portion of Private Placement Backed by Palisades Goldcorp and Funds Managed by Sprott Asset Managment LLP

Retrieved on: 
Tuesday, February 9, 2021

The First Tranche consisted of 2,855,000 non flow through units (the "NFT Units") at a price of $0.30 per NFT Unit for proceeds of $856,500.

Key Points: 
  • The First Tranche consisted of 2,855,000 non flow through units (the "NFT Units") at a price of $0.30 per NFT Unit for proceeds of $856,500.
  • The number of NFT Units issued exceeded that anticipated in the February 1, 2021 news release by 55,000 NFT Units.
  • A syndicate led by Palisades Goldcorp Ltd. purchased a total of 1,600,000 of the NFT Units in the First Tranche.
  • Funds managed by Sprott Asset Management LLP have agreed to purchase 2,857,143 FT Units of the Private Placement.

Valorem Completes First Tranche of Non-Brokered Private Placement

Retrieved on: 
Friday, January 29, 2021

VANCOUVER, British Columbia, Jan. 28, 2021 (GLOBE NEWSWIRE) -- VALOREM RESOURCES INC. (the Company or Valorem) (CSE: VALU) (Frankfurt: 1XW1) is pleased to announce that it has closed the first tranche of a non-brokered private placement (the First Tranche).

Key Points: 
  • VANCOUVER, British Columbia, Jan. 28, 2021 (GLOBE NEWSWIRE) -- VALOREM RESOURCES INC. (the Company or Valorem) (CSE: VALU) (Frankfurt: 1XW1) is pleased to announce that it has closed the first tranche of a non-brokered private placement (the First Tranche).
  • Each Unit consists of one (1) common share of the Company (a Common Share) and one (1) transferable share purchase warrant (a Warrant).
  • The securities issued pursuant to the First Tranche are subject to a four (4) month hold period.
  • The proceeds of the Offering are planned to be used by Valorem for general ongoing working capital and corporate purposes.

KBRA Assigns Preliminary Ratings to FREED ABS Trust 2021-1CP

Retrieved on: 
Thursday, January 28, 2021

Kroll Bond Rating Agency (KBRA) assigns preliminary ratings to three classes of notes issued by FREED ABS Trust 2021-1CP (FREED 2021-1CP), a $186.5 million consumer loan asset-backed securities transaction.

Key Points: 
  • Kroll Bond Rating Agency (KBRA) assigns preliminary ratings to three classes of notes issued by FREED ABS Trust 2021-1CP (FREED 2021-1CP), a $186.5 million consumer loan asset-backed securities transaction.
  • The preliminary ratings reflect initial credit enhancement levels of 40.25% for the Class A notes, 26.75% for the Class B notes and 16.00% for the Class C notes.
  • This transaction represents the eighth overall ABS securitization collateralized by unsecured consumer loans originated through Freedom Financial Asset Management (FFAM or the Company).
  • KBRA also conducted an operational assessment of FFAM, as well as a review of the transactions legal structure and transaction documents.

EQS-News: Rapid Nutrition PLC: Rapid Nutrition attracts USD 1 million investment with Swiss company Nice & Green to fund its growth strategy

Retrieved on: 
Wednesday, January 27, 2021

In consideration for the issuance of convertible notes Nice & Green has committed to invest USD 1 million in 4 tranches over a period of 24 months.

Key Points: 
  • In consideration for the issuance of convertible notes Nice & Green has committed to invest USD 1 million in 4 tranches over a period of 24 months.
  • The principal amount of each convertible note is, at Rapid Nutrition's discretion, either payable by way of conversion into ordinary shares of the company, or in cash.
  • "We have been watching Rapid Nutrition's development for some time now and are proud to partner with Rapid Nutrition via subscription of Convertible notes to support their growth strategy.
  • We look forward supporting Rapid Nutrition with regular tranches Nice & Green commits to buy," says CEO Marc Cattelani.

iSIGN Media Announces Closing of the Second Tranche of its Previously Announced Private Placement of up to $236,700

Retrieved on: 
Wednesday, January 27, 2021

TORONTO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- iSIGN Media Solutions Inc. (iSIGN or Company) (TSX-V: ISD) (OTC: ISDSF), a leading provider of interactive mobile proximity marketing and public security alert solutions announced that it has closed the second tranche (the Second Tranche) of its previously announced non-brokered private placement (Placement) of up to $236,700.

Key Points: 
  • TORONTO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- iSIGN Media Solutions Inc. (iSIGN or Company) (TSX-V: ISD) (OTC: ISDSF), a leading provider of interactive mobile proximity marketing and public security alert solutions announced that it has closed the second tranche (the Second Tranche) of its previously announced non-brokered private placement (Placement) of up to $236,700.
  • The Company completed the Second Tranche of the Placement for total gross proceeds of $20,000 by issuing 400,000 Units (Units) at a price of $0.05 per Unit.
  • Each Warrant entitles the holder to purchase one Common Share at a price of $0.075 for a period of 24 months from the date of closing.
  • The forward-looking statements are not historical facts but reflect iSIGN Medias current expectations regarding future results or events.